BIOMARKER:

PDGFRA mutation

Entrez ID:

Related biomarkers:

‹

›

PDGFRA mutation PDGFRA mutation	Gastrointestinal Stromal Tumor GIST	ripretinib Sensitive: B - Late Trials
PDGFRA mutation PDGFRA mutation	Gastric Cancer Gastric Cancer	imatinib Sensitive: B - Late Trials
PDGFRA mutation PDGFRA mutation	Gastrointestinal Stromal Tumor GIST	avapritinib Sensitive: C2 – Inclusion Criteria
PDGFRA mutation PDGFRA mutation	Gastrointestinal Stromal Tumor GIST	imatinib Sensitive: C2 – Inclusion Criteria
PDGFRA mutation PDGFRA mutation	Non Small Cell Lung Cancer NSCLC	nintedanib Sensitive: C3 – Early Trials
PDGFRA mutation PDGFRA mutation	Gastrointestinal Stromal Tumor GIST	AZD1775 Sensitive: D – Preclinical
PDGFRA mutation PDGFRA mutation	Gastrointestinal Stromal Tumor GIST	AZD1775 + avapritinib Sensitive: D – Preclinical

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

Associations